Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Rule 2.9 Announcement

12 Oct 2020 07:00

RNS Number : 7091B
Redcentric PLC
12 October 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO, OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

 

12 October 2020

Redcentric PLC

("Redcentric" or the "Company")

 

Rule 2.9 Announcement

In accordance with Rule 2.9 of the Code, Redcentric confirms that, as at the close of business on 9 October 2020, and excluding any Treasury Shares, it had in issue 155,551,300 ordinary shares of 0.1 pence each. The International Securities Identification Number (ISIN) for Redcentric's ordinary shares is GB00B7TW1V39.

 

Enquiries:

 

Redcentric

Peter Brotherton, Chief Executive Officer

+44 (0)800 983 2522

David Senior, Chief Financial Officer

Stifel Nicolaus Europe Limited (Sole Financial Adviser)

Patrick Seely / Hamish Shah

Nick Adams / Alex Price

 

+44 (0) 20 7710 7600

finnCap Limited (Nomad and Broker)

+44 (0)20 7220 0500

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

Disclosure requirements of the Code

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTTVFLFFBBLLFBQ
Date   Source Headline
1st Jun 20267:01 amRNSAppointment of Chief Financial Officer
1st Jun 20267:00 amRNSTrading Update
13th May 20261:25 pmRNSCapital Reduction Result of General Meeting
12th May 20267:00 amRNSExercise of Options
1st May 20267:00 amRNSCompletion of Sale of Redcentric Data Centres Ltd
24th Apr 20267:00 amRNSProposed Capital Reduction & Notice of GM
14th Apr 20267:00 amRNSExercise of Options
8th Apr 202612:55 pmRNSDirector/PDMR Shareholdings
19th Mar 20263:26 pmRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
23rd Feb 20261:00 pmRNSHolding(s) in Company
20th Feb 20267:00 amRNSExercise of Options
9th Jan 202610:09 amRNSExercise of Options
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 20257:00 amRNSExercise of Options
31st Dec 20257:00 amRNSExercise of Options
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
22nd Dec 202511:46 amRNSGrant of Options
22nd Dec 202511:46 amRNSGrant of Options
12th Dec 20253:49 pmRNSDirector/PDMR Shareholdings
11th Dec 20257:00 amRNSExercise of Options
10th Dec 20257:00 amRNSHalf Year Results
4th Dec 20257:00 amRNS-RPresentation via Investor Meet Company
14th Nov 20257:00 amRNSExercise of Options
6th Nov 20258:00 amRNSSAYE Share Option Scheme
5th Nov 20257:00 amRNSH1 Trading Update and Notice of Results
27th Oct 20254:36 pmRNSHolding(s) in Company
24th Oct 20257:00 amRNSExercise of Options
23rd Oct 20257:00 amRNSDisposal of Redcentric Data Centres Limited
20th Oct 20254:48 pmRNSResult of AGM
17th Oct 202512:40 pmRNSExercise of Options
13th Oct 20259:40 amRNSExercise of Options
3rd Oct 20257:00 amRNSExercise of Options
25th Sep 20257:00 amRNSPublication of Annual Report and Notice of AGM
24th Sep 20257:00 amRNSFinal Results
2nd Sep 20257:00 amRNSNotice of Final Results
22nd Aug 20251:13 pmRNSResponse to recent press speculation
19th Aug 20257:00 amRNSAppointment of Chief Financial Officer
1st Aug 20257:00 amRNSExercise of Options
7th Jul 20257:00 amRNSExercise of Options
23rd Jun 20257:00 amRNSExercise of Options
17th Jun 20257:00 amRNSHolding(s) in Company
28th May 20253:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.